ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Allena Pharmaceuticals Inc

Allena Pharmaceuticals Inc (ALNA)

0.075
0.00
( 0.00% )
Updated: 19:00:00

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
0.075
Bid
0.0825
Ask
0.0832
Volume
-
0.00 Day's Range 0.00
0.00 52 Week Range 0.00
Previous Close
0.075
Open
-
Last Trade
Last Trade Time
-
Average Volume (3m)
-
Financial Volume
-
VWAP
-

ALNA Latest News

Allena Pharmaceuticals Announces New Meeting Date and New Record Date for Special Meeting to Approve Reverse Stock Split

NEWTON, Mass., July 12, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class...

Allena Pharmaceuticals Announces Rescheduling of Special Meeting to Approve Reverse Stock Split

NEWTON, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage, biopharmaceutical company dedicated to developing and commercializing first-in-class...

Allena Pharmaceuticals Gets Fast Track Designation for Kidney Disease Treatment

By Chris Wack Allena Pharmaceuticals Inc. said its orally-administered, urate-degrading enzyme, ALLN-346, has received Fast Track designation from the U.S. Food and Drug Administration. ALLN-346...

Allena Pharmaceuticals to Host Key Opinion Leader Webinar Focused on ALLN-346 for the Treatment of Gout in Patients with Chro...

NEWTON, Mass., June 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing...

Allena Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

-- Enrollment ongoing in Phase 3 URIROX-2 clinical trial of reloxaliase; interim analysis expected 2Q or 3Q 2022 Enrolling healthy volunteers in Phase 1b MAD study of ALLN-346; initial data...

Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEWTON, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing...

Allena Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NEWTON, Mass., April 08, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ:ALNA), a late-stage biopharmaceutical company dedicated to discovering, developing and commercializing...

Allena Pharmaceuticals Appoints Mark J. Fitzpatrick to its Board of Directors

NEWTON, Mass., April 07, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class...

Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

    -- Reloxaliase continues to progress through ongoing pivotal Phase 3 URIROX-2 trial for enteric hyperoxaluria -- -- ALLN-346 poised to enter Phase 1 multiple-ascending dose and Phase 2a trials...

Allena Pharmaceuticals to Present at Upcoming Investor Conferences in March

NEWTON, Mass., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Allena Pharmaceuticals, Inc. (NASDAQ: ALNA), a late-stage biopharmaceutical company dedicated to developing and commercializing first-in-class...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SPPLSIMPPLE Ltd
$ 0.9706
(203.31%)
327.44M
NUWENewellis Inc
$ 2.839
(108.75%)
92.86M
STAFStaffing 360 Solutions Inc
$ 2.8187
(65.81%)
49.32M
ADNAdvent Technologies Holdings Inc
$ 3.0757
(61.88%)
60.99M
OMICSingular Genomics Systems Inc
$ 21.55
(60.10%)
288.84k
FIACFocus Impact Acquisition Corporation
$ 1.00
(-88.74%)
172
TOIIWOncology Institute Inc
$ 0.0101
(-47.67%)
58.22k
SSPEW Scripps Company
$ 2.1801
(-38.07%)
3.3M
INVZWInnoviz Technologies Ltd
$ 0.0642
(-33.13%)
2k
GCTKGlucoTrack Inc
$ 1.18
(-32.18%)
70.42k
SPPLSIMPPLE Ltd
$ 0.9706
(203.31%)
327.44M
ELABElevai Labs Inc
$ 0.0199
(-31.14%)
222.9M
SQQQProShares UltraPro Short QQQ
$ 7.4501
(0.14%)
135.55M
NVDANVIDIA Corporation
$ 138.155
(2.03%)
132.13M
PLUGPlug Power Inc
$ 2.4693
(18.15%)
93.48M

Discussion

View Full Feed
Humbert Humbert 4 minutes ago
Absolutely, BNCM's time will come, shortly.
BNCM
TheRealMrPirate TheRealMrPirate 4 minutes ago
FKA bioaq Cassels has no involvement in the bankruptcy proceedings of former BioAmber.
Yes, PWC signed off on it, court approved.
They have also been discharged and the liquidation finalized.
Sorry about your luck.


investorshub.advfn.com/uimage/uploads/20
tbonaces80 tbonaces80 4 minutes ago
Close above $4
NUWE
Joesocc1 Joesocc1 4 minutes ago
Yea that likely was voter fraud in 2020 but in nov 2016 just the idea of trump running was enough to get this stock to 3-4$, even at nov 2020 the stock was above $2. So to be well under 2 within 1 day makes no sense to me. 
FNMA
pos_stock_hoarder pos_stock_hoarder 4 minutes ago
Enough already. Fix the slowness issue. Causes tons of duplicate posts too.
Lone Clone Lone Clone 4 minutes ago
Banyan Drilling Confirms High Grade Structural Controls and Grade Continuity at Powerline, AurMac Project

https://www.accesswire.com/938498/banyan-drilling-confirms-high-grade-structural-controls-and-grade-continuity-at-powerline-aurmac-project

Monday, 04 November 2024
IronChefQuezon IronChefQuezon 4 minutes ago
Wow just saw this is going crazy!!!
APRU
bigworld bigworld 5 minutes ago
gfp: Three scenarios could unfurl tomorrow, two of them would increase volatility. 1) Trump wins outright and the Republicans overcome the Steal 2.0 and take the House and Senate: The equity markets would likely rally, the VIX would drop and I would cash out my UVXY. The metals would also likely cor
UVXY VIX
236T568 236T568 5 minutes ago
Philly DA - F around and Find out!

https://x.com/LeaundraRoss/status/1853492420492619791
burner67 burner67 5 minutes ago
Wow...you're really bored
BEGI
big bopper1 big bopper1 5 minutes ago
Exactly,no details. Why
CYDY
Buckey Buckey 5 minutes ago
ENSV did move to .08 from .055 level but i missed it however did nibble on EFSH which has been all over the place recently in at .30
EFSH ENSV
brooktrail1933 brooktrail1933 5 minutes ago
Reading comprehension is a good thing. The 13% IDH-mutant population is only part of the problem. The SurVax trial also had a significant overweight of better-performing, longer-living methylated patients. Our trial had about 60-40 unmethylated/methylated patients. Since you are so on the ball,
NWBO
The ELTP King The ELTP King 5 minutes ago
Where's his guess? That's what I thought...

He consistently leaves our Hgils too.
ELTP
Latenightmike57 Latenightmike57 5 minutes ago
seriously? lol. Let’s break it down so even you would understand it
Late- that’s spelled correctly
Night- same here , spelled right
Mike- spelled correctly

As usual you are wrong and I am right.
No wonder nobody you’re posting to yourself on 5 differe
SMME
condor1 condor1 5 minutes ago
From the photos of Nov 3rd, it appears to me that there is a conveyor system OUT of Building B-2, in which the processed ore will be conveyored out to awaiting trucks, which will be positioned under the conveyor drop , and will drive back the load to the Amparo ore piles. More efficiency / less labo
AABB
surfkast surfkast 5 minutes ago
I agree. Sadly some can't be educated. Too bad when we post facts, the response is usually a childish one or a personal attack. It would be so much more intelligent if some would challenge what they perceive as bashing with facts/links to create an intelligent conversational exchange.
HIRU
Wayne R Wayne R 6 minutes ago
Too late, when I cook lasagna now, I make 2 dishes, one is with spinach, the other, for me and my kids, beef and spinach.

I find the spinach helps to keep the noodles hydrated
Monksdream Monksdream 6 minutes ago
SERV, 10Q 11/7
https://investorshub.advfn.com/uimage/uploads/2024/11/4/z[ntnIMG_3061.gif
SERV
cardmaster114 cardmaster114 6 minutes ago
I guess I was right. CE designation.
HVCW
fink fink 6 minutes ago
No worries here. I still have a great average in all 3. So I got that to fall back on. But it's getting damn close.

I've got limited dry powder and hard to say which I want more of.

Really I just want to get through tomorrow without the country burning.
It's a
ZHUD
KOmani KOmani 6 minutes ago
Yorkville is diluting.

However, someone is buying the shares....

I guess the move for now is buy at low $3 and sell on the way up.

I want to believe that this can run.

The issue is that Triller/AGBA could not find outside investors willing
ILLR
pappythom1 pappythom1 6 minutes ago
i like drill baby,drill !!
QSEP